Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paolo Forte
Observed name:
P. Forte
Institution:
Azienda Ospedaliero-Universitaria Careggi
Observed institutions:
University of Siena,
Università Cattolica del Sacro Cuore,
International Hellenic University,
Agostino Gemelli University Polyclinic,
Universidade Federal de Santa Maria,
Azienda Ospedaliero-Universitaria Careggi,
Azienda Ospedaliera Treviglio,
University of Florence
show all 8
ORCID:
0000-0002-6504-2899
Observed ORCID:
0000-0002-6504-2899
OpenAlex ID:
A5102837907
Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients
2006
·
Gloria Taliani
, Giulia Gemignani
, et al.
·
Gastroenterology
·
101
PDF
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2021
·
Matteo Lulli
, Laura Del Coco
, et al.
·
Cancer Research
·
41
PDF
Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
2022
·
Erica Nicola Lynch
, Claudia Campani
, et al.
·
World Journal of Hepatology
·
39
PDF
Decline in the exposure to hepatitis A and B infections in children in Naples, Italy
1989
·
P. D'Argenio
, D. Esposito
, et al.
·
Public Health
·
36
Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
2014
·
Andrea L Inghilesi
, Donatella Gallori
, et al.
·
World Journal of Gastroenterology
·
24
Is green tea a potential trigger for autoimmune hepatitis?
2013
·
Eugenia Gallo
, Valentina Maggini
, et al.
·
Phytomedicine
·
23
Pancreatitis induced by pegylated interferon alfa‐2b in a patient affected by chronic hepatitis C
2004
·
Enrica Cecchi
, Paolo Forte
, et al.
·
Emergency Medicine Australasia
·
19
Practical insights into chronic management of hepatic Wilson’s disease
2022
·
Erica Nicola Lynch
, Claudia Campani
, et al.
·
World Journal of Clinical Cases
·
11
PDF
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany
2018
·
Cristina Stasi
, Caterina Silvestri
, et al.
·
Current Medical Research and Opinion
·
11
Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience
2014
·
Alessandra Mangia
, Giovanni Cenderello
, et al.
·
PLoS ONE
·
9
PDF
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
2018
·
Cristina Stasi
, Caterina Silvestri
, et al.
·
World Journal of Hepatology
·
7
PDF
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial
2013
·
Simona Francioso
, Cristiana Almerighi
, et al.
·
Digestive and Liver Disease
·
7
High SVR Rates with SMV + SOF in HCV GT1 and GT4 Patients with Cirrhosis or Advanced Fibrosis: A Real Practice Analysis from a Large Regional Database in Tuscany, Italy
2016
·
E. Salomoni
, E. Gianni
, et al.
·
Journal of Hepatology
·
2
Sustained Virological Response in HCV Patients Treated with Daclatasvir+Sofosbuvir, with or without Ribavirin: A Multicenter, Field-Practice Experience
2017
·
Rodolfo Sacco
, Elena Salomoni
, et al.
·
Gastroenterology
·
1
Safety of Simeprevir-Based Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Observational Study
2016
·
M. Colombo
, M. Russello
, et al.
·
Journal of Hepatology
·
1
1135 Il28b Cc Genotype Is Associated With Higher On-treatment-response Rates in Pts With Hcv-3: Interim Results of the Write Study
2012
·
V. Piazzolla
, P. Forte
, et al.
·
Journal of Hepatology
·
1
THU-184 Fatigue is not influenced by chronotype and is reported to be mainly muscular in patients with primary biliary cholangitis
2024
·
Erica Nicola Lynch
, Pietro Rossi
, et al.
·
Journal of Hepatology
Oc.05.9: Fatigue Is Not Influenced by Chronotype and Is Reported to Be Mainly Muscular in Patients With Primary Biliary Cholangitis
2024
·
E.N. Lynch
, P. Rossi
, et al.
·
Digestive and Liver Disease
Fatigue is not influenced by chronotype and is reported to be mainly muscular in patients with primary biliary cholangitis
2024
·
E.N. Lynch
, P. Rossi
, et al.
·
Digestive and Liver Disease
Table S3 from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Table S1 from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Supplementary Figure Legends from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Supplementary Methods from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Table S2 from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Table S1 from DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer
2023
·
Matteo Lulli
, Laura Del Coco
, et al.
Show more works
View as search
Works count:
34
Citation count:
333
H-index:
9
I10-index:
9
Year
Topic
Type